Overexpression of microRNA‑620 Facilitates the Resistance of Triple Negative Breast Cancer Cells to Gemcitabine Treatment by Targeting DCTD

Experimental and Therapeutic Medicine - Greece
doi 10.3892/etm.2019.7601
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Dasatinib Sensitises Triple Negative Breast Cancer Cells to Chemotherapy by Targeting Breast Cancer Stem Cells

British Journal of Cancer
Cancer ResearchOncology
2018English

MicroRNA‑124 Suppresses Cell Proliferation and Invasion of Triple Negative Breast Cancer Cells by Targeting STAT3

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

Targeting MYC for Triple-Negative Breast Cancer Treatment

Oncoscience
Cancer ResearchOncology
2018English

MicroRNA-203 Suppresses Cell Proliferation and Migration by Targeting BIRC5 and LASP1 in Human Triple-Negative Breast Cancer Cells

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2012English

Development of a Vaccine Targeting Triple-Negative Breast Cancer

2013English

MicroRNA-455-3p Promotes Invasion and Migration in Triple Negative Breast Cancer by Targeting Tumor Suppressor EI24

Oncotarget
Oncology
2016English

Targeting DNA Methylation for Treating Triple-Negative Breast Cancer

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2019English

FZD7 in Triple Negative Breast Cancer Cells

2011English

Silencing of CXCR4 Sensitizes Triple-Negative Breast Cancer Cells to Cisplatin

Oncotarget
Oncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy